Glucocorticoid Receptors Are Making a Comeback in Corticotroph Tumorigenesis
Open Access
- 22 December 2021
- journal article
- editorial
- Published by The Endocrine Society in Endocrinology
- Vol. 163 (2)
Abstract
Partial resistance to the negative glucocorticoid (GC) feedback is a defining feature of corticotroph tumors and the rationale behind utilizing the dexamethasonKeywords
Funding Information
- Deutsche Forschungsgemeinschaft (314061271)
This publication has 11 references indexed in Scilit:
- Duality of glucocorticoid action in cancer: tumor-suppressor or oncogene?Endocrine-Related Cancer, 2021
- Pangenomic Classification of Pituitary Neuroendocrine TumorsCancer Cell, 2020
- The New Genetic Landscape of Cushing’s Disease: Deubiquitinases in the SpotlightCancers, 2019
- TheCables1Gene in Glucocorticoid Regulation of Pituitary Corticotrope Growth and Cushing DiseaseThe Journal of Clinical Endocrinology & Metabolism, 2016
- Mutations in the deubiquitinase gene USP8 cause Cushing's diseaseNature Genetics, 2014
- Comprehensive Overview of the Structure and Regulation of the Glucocorticoid ReceptorEndocrine Reviews, 2014
- Familial Glucocorticoid Receptor Haploinsufficiency by Non-Sense Mediated mRNA Decay, Adrenal Hyperplasia and Apparent Mineralocorticoid ExcessPLOS ONE, 2010
- Generalized Glucocorticoid Resistance: Clinical Aspects, Molecular Mechanisms, and Implications of a Rare Genetic DisorderThe Journal of Clinical Endocrinology & Metabolism, 2008
- The Molecular Pathogenesis of Corticotroph TumorsEndocrine Reviews, 1999
- Nelson's syndrome associated with a somatic frame shift mutation in the glucocorticoid receptor gene.The Journal of Clinical Endocrinology & Metabolism, 1996